FOXC1 is also being recognized in a wide range of cancers, including acute myeloid leukemia [31], hepatocellular carcinoma [32], renal cell carcinoma [33], gastric cancer [34], and non-small cell lung cancer [35]. Here, FOXC1 is linked to hepatocellular carcinoma.